Philadelphia biotech firm backed by more than $130M names new CEO
A Philadelphia biotechnology company founded seven years ago by two former Johnson & Johnson executives has a new leader.
United Therapeutics' president sells shares worth $3.48 million
Michael Benkowitz, President and COO of United Therapeutics Corp (NASDAQ:UTHR), a $15.77 billion market cap company with an "Excellent" financial health rating according to InvestingPro, executed a ...